研发与技术页面-技术平台-Technology platform
Technology platform
Our technological innovation in antibody research, development, and production separates us from our competitors.
The company has built a research, development and industrialization technology platform focusing on original antibody drugs. With rich animal disease models and a variety of advanced analysis techniques, the company has developed monoclonal antibody-drug conjugates and double-specific antibody drugs for a variety of diseases such as malignant tumors, diabetes, respiratory disease and autoimmune diseases.
Independent research and development production platform
Core And Key Technologies
Our goal is to utilize different design and screening technology during the antibody drug molecule discovery stage combined with domestic and foreign processes to create high quality and efficient antibody drugs that meet global standards for patients.
By identifying important targets of the immune system, we can activate or suppress the immune system and treat serious diseases.
High throughput antibody phage screening technology
Through the mature antibody phage screening platform, antibody molecules with high affinity, excellent physical and chemical properties and biological activities can be quickly screened for different targets in a short time.
Humanization of antibodies
Humanized antibody molecules can be quickly obtained by the method of 3D structure homology modeling through amino acid sequence alignment. It showed that the antibody was highly humanized and had excellent biological activity.
Construction of high expression engineering cell lines
The construction platform of engineering cell lines with independent intellectual property rights was established. The engineering cell lines with high antibody expression can be screened in a short time. Moreover, the engineering cell lines have good long-term stability and can meet the needs of different scale production.
We have international standard CMC capability and GMP manufacturing capability
Our company has an international advanced antibody process development and production equipment which allows us to establish the leading domestic and foreign antibody process, optimization platform and production platform. Therefore, we are able to achieve high quality and large-scale production of antibody drugs.
Innovative antibody research and development and production of a variety of technical platforms
The company integrates research and development experience to climb to the peak of research and development technology. To achieve this, we have a biologic drug development platform mapping out our process.
Innovative antibody discovery platform
Quality control platform
Screening platform for high-expression mammalian cell lines
Process optimization platform
Monoclonal antibody development platform
Pilot production platform
Bispecific antibody development platform
Clinical Medical platform
Therapeutic vaccine development platform
Clinical execution Platform
Pharmacology and toxicology platform
Large-scale industrialization platform
Complete experimental equipment
Eastern Biotech has a variety of advanced technology of high precision instruments. The required facilities are complete, which can ensure the high standard and high efficiency of drug development and production.
Uncle High throughput multifunctional protein stability analyzer
AKTA avant protein Purification System
Monoclonal cell tracking imager
Attune Nxt flow cytometry analyzer
MSD(Meso Scale Discovery)
Biomacromolecule Interaction Instrument (Biacore)
Follow us
Follow the official WeChat official account
Or search "Oriental Baitai"
More exciting waiting for you!
Address: No. 2, Rongjing East Street, Beijing Economic and Technological Development Zone
Tel.: 010-51571019
Email: ebt@east-bt.com
Copyright 2021 Beijing Dongfang Baitai Biotechnology Co., Ltd SEO 京ICP备2023010711号-1
